Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

Medicare opts not to make CT radiation-related quality measure mandatory in 2027
The measure evaluates the proportion of scans that exceed certain thresholds for image noise or radiation dose across 18 categories.
Emphysema on baseline lung cancer CT a sign of future mortality risk
“Lung cancer screening shouldn’t just be looking for nodules. That’s a small part of what we see on the CT scan.”
Key trends in nuclear cardiology take center stage at ASNC 2025
Wael Jaber, MD, chair of the 2025 American Society of Nuclear Cardiology annual meeting, shared some key takeaways from the conference. “This is no longer just about imaging for coronary disease," he explained. "Nuclear cardiology now helps guide therapy across a wide range of conditions."
Lantheus misled investors about blockbuster imaging agent, class action lawsuit claims
Plaintiff attorneys claim the Massachusetts-based company shattered the competitive position of Pylarify, a PET imaging agent for prostate cancer.
GE HealthCare to acquire Alzheimer’s imaging AI firm Icometrix
Founded in 2011 and based in Belgium, the AI firm offers the first software for automating brain assessments needed to administer disease therapies from Biogen and Eli Lilly.

NRC okays U.S. isotope plant construction application

SHINE Medical Technologies, a Wisconsin-based producer of medical isotope technologies, announced Dec. 3 that the U.S. Nuclear Regulatory Committee (NRC) has accepted the second and final portion of their application for a construction permit to build an accelerator plant for medical isotopes including molybdenum-99, which would in turn create a U.S. supply of technetium-99.

Several new genes identified in Alzheimer’s pathology

A Large-scale DNA analysis has led to the discovery of 11 new genes involved in the development of Alzheimer’s disease, according to a study published Oct. 27 in Nature Genetics.

Early detection of MS possible with novel molecular sensor

Using a molecular sensor that finds the protein fibrinogen in the blood-brain barrier, researchers are able to detect early signs of multiple sclerosis (MS) before any outward symptoms of disease. This could lead to better therapies provided earlier in the disease process, according to a study published Nov. 29 in the Annals of Neurology.

Blood-brain barrier cells could unlock new Alzheimer’s disease diagnostics and therapy

Targeting the loss of blood-brain barrier cells now implicated in the development of Alzheimer’s disease (AD) may lead to a new diagnostic paradigm and a way forward for drug therapies that improve neurovascular health, according to a study published Dec. 13 in Nature Communications.

New vitamin B12 cancer biomarker on the block

An investigative SPECT/CT imaging agent targets tumor cells via a vitamin B12 carrier, according to research published online Dec. 12 by the Journal of Nuclear Medicine.

Drug treatment could suppress cancer cells in the brain

The growth of brain tumor initiating cells positively linked to glioma development and recurrence may be altered by an immunotherapy, according to a study published online Dec. 8 by Nature Neuroscience.

Lymphoseek lands FDA fast track

Navidea Biopharmaceuticals, makers of technetium-99m tilmanocept injection, otherwise known as Lymphoseek, announced FDA status for fast-track approval for the detection of lymph node involvement in head and neck cancers, according to a statement Dec. 10.

Prostate cancer patients live longer by combining chemo with hormone therapies

Preliminary results of a clinical trial for the chemotherapy drug docetaxel indicate that hormone-sensitive metastatic prostate cancer patients who added hormone therapy to the mix experienced significantly prolonged survival, according to a Dec. 5 statement by the National Institutes of Health (NIH).

Medical Imaging

Medicare opts not to make CT radiation-related quality measure mandatory in 2027

Emphysema on baseline lung cancer CT a sign of future mortality risk

Key trends in nuclear cardiology take center stage at ASNC 2025

Lantheus misled investors about blockbuster imaging agent, class action lawsuit claims

GE HealthCare to acquire Alzheimer’s imaging AI firm Icometrix